Chief Executive Officer
With more than 25 years of experience in pharmaceutical industry, Abdulhamid has developed a strong foundation in executive management, financial management, portfolio management, strategic partnerships as well as many others. He joined JPM as Chief Executive Officer on 1st of December 2024. He holds a B.Sc. in Pharmacy from the University of Jordan and MBA from NYIT. Before joining JPM, he held different positions at different pharmaceutical companies; Eli Lilly, Hoffmann La Roche, Hikma & lately MS Pharma. Throughout his career, he led diverse teams, developed cross-functional strategies and managed complex strategic projects, with commitments to drive excellence and innovation.
“As CEO of JPM, I will focus on driving strategic growth and operational excellence across all facets of the organization. My leadership will be centered around fostering innovation, enhancing customer satisfaction, and expanding our market presence globally. I will focus on promoting a culture of transparency, agility and continuous improvement. My role is to lead JPM into next phase of success, positioning the company as a trusted partner and a leader in driving innovation within the pharmaceutical sector.”